<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02781519</url>
  </required_header>
  <id_info>
    <org_study_id>1505015940</org_study_id>
    <nct_id>NCT02781519</nct_id>
  </id_info>
  <brief_title>Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans</brief_title>
  <acronym>THC-Gender</acronym>
  <official_title>Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to characterize the acute effects of cannabinoids in women
      relative to men and to begin probing the mechanisms that may underlie gender differences.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rewarding Effects measured by Visual Analog Scale (VAS)</measure>
    <time_frame>changes in &quot;high&quot; assessed over the following timepoints: baseline, +10, +80, and +200 minutes after THC infusion begins</time_frame>
    <description>subjective measure of THC induced &quot;high&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Verbal Learning: measured by Rey Auditory Verbal Learning Test (AVLT)</measure>
    <time_frame>25 minutes after THC infusion begins</time_frame>
    <description>measured as delay recall on the AVLT</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cannabis</condition>
  <arm_group>
    <arm_group_label>THC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active THC (0.015mg/kg) administered intravenously over 10 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control: small amount of alcohol intravenously (quarter teaspoon), with no THC over 10 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>THC</intervention_name>
    <description>Active THC (0.015mg/kg) administered over 10 minutes</description>
    <arm_group_label>THC</arm_group_label>
    <other_name>Delta-9-Tetrahydrocannabinol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Control: small amount of alcohol (quarter teaspoon), with no THC over 10 minutes</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least one lifetime exposure to cannabis

          -  good physical and mental health

        Exclusion Criteria:

          -  cannabis naive individuals

          -  major current or recent stressors

          -  taking estrogen supplements or oral contraceptive pills (for women)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christina Luddy, BS</last_name>
    <phone>203-932-5711</phone>
    <phone_ext>4549</phone_ext>
    <email>christina.luddy@yale.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Luddy, BS</last_name>
      <phone>203-932-5711</phone>
      <phone_ext>4549</phone_ext>
      <email>christina.luddy@yale.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2016</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Mohini Ranganathan</investigator_full_name>
    <investigator_title>Assistant Professor of Psychiatry</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dronabinol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

